[Skip navigation] FDA, Office of Planning

Report on PDUFA Goals: Manufacturing Supplements

Goal: Review and act upon complete manufacturing supplements to NDAs and BLAs

The review performance goals for manufacturing supplements that do not require FDA approval before the changes they specify can be enacted do not change over the five years of PDUFA ii. For manufacturing supplements that do require FDA's approval, the goal times decrease from 6 months for FY 98 submissions to 4 months for FY 02 submissions.

Goals

On-Time Performance by Submission Year

FY 98

FY 99

FY 00

FY 01

FY 02

Prior approval not required

6 months

90% on time

90%

90%

90%

90%

Prior approval required

6 months

4 months

90%

90%

30%

90%

50%

90%

70%

90%

Workload

Workload -- Manufacturing supplements filed (Total / Prior Approval Required):

FY 96

FY 97

FY 98

FY 99

FY 00 4

to NDAs

1,218

1,262

1,463

1,459 (900)

1,446 (708)

to BLAs

261

338

371

477 (259)

569 (244)

PDUFA total

1,479

1,600

1,834

1,936 (1,159)

2,015 (952)

Performance:

FY 99 Submissions:

Ninety-eight percent of the manufacturing supplements that did not require prior FDA approval submitted in FY 99 were reviewed within 6 months. That level of performance exceeded the 90 percent on-time review goal.

Ninety-eight percent of the manufacturing supplements that required prior FDA approval submitted in FY 99 also were reviewed within 6 months. Seventy-six percent of these were reviewed within 4 months. That level of performance exceeded FY 99's goals of 90 percent and 30 percent respectively.

FY 99 Submissions

Reviewed and acted upon

Number on time

Percent on time

Prior approval not required

6 months

777

759

98

Prior approval required

6 months

4 months

1159

1141

887

98

76

FY 00 Submissions:

As of September 30, 2000, almost 59 percent of the manufacturing supplements that do not require prior approval, and 64 percent of those that do require prior approval had been reviewed. Ninety-nine percent of both categories of manufacturing supplements had been reviewed within 6 months, and 82 percent of those requiring prior approval had been reviewed within 4 months. Although it is too early to make a final determination with only 61 percent of the submissions reviewed, performance in all categories is well above the FY 00 review goals.

FY 00 Submissions

Reviewed and acted upon

Number on time

Percent on time

Prior approval not required

6 months

625

620

99

Prior approval required

6 months

4 months

610

605

503

99

82



Next Page | Table of Contents | Previous Page



FDA Home Page
| Search | A-Z index | Site Map | Contact FDA

FDA/Office of Planning
Web page created by cm 2001-MAR-01.